The global radiation detection, monitoring, and safety market was valued at USD 1.53 billion in 2023 and is expected to reach USD 2.52 billion by 2030, expanding at a CAGR of 7.4% from 2024 to 2030. The increasing prevalence of cancer worldwide has led to a surge in the adoption of nuclear medicine and radiation therapy, which is anticipated to significantly fuel market growth during the forecast period.

According to data published by the World Health Organization (WHO) in February 2024, the International Agency for Research on Cancer (IARC) reported approximately 20 million new cancer cases and 9.7 million cancer-related deaths in 2022. Research further reveals that 1 in 5 individuals is diagnosed with cancer during their lifetime. These rising statistics are expected to amplify the demand for radiation therapy in cancer diagnosis and treatment over the coming years.

The application of nuclear medicine, utilizing radioactive tracers to detect and monitor diseases at a molecular level, enables early cancer detection and provides detailed insights into disease progression. These advanced imaging systems offer a significant advantage over traditional anatomical imaging, which often fails to reveal the molecular origins of disease. As such, their growing adoption is anticipated to further boost market expansion.

In addition, growing awareness and regulatory efforts around radiation safety are driving demand for safety equipment. Agencies such as the U.S. Food and Drug Administration (FDA) have introduced updated performance standards for diagnostic X-ray systems, laser therapies, and radiation safety protocols across medical applications. Similarly, organizations like the Centers for Disease Control and Prevention (CDC) and the International Atomic Energy Agency (IAEA) are actively supporting initiatives related to radiation safety training, emergency preparedness, and safe use of nuclear technologies—all contributing to rising demand for radiation safety instruments.

Key Market Trends & Insights

• North America led the global radiation detection, monitoring, and safety market in 2023.

• Within North America, the U.S. accounted for 77.4% of the regional market share.

• By product type, personal dosimeters dominated the segment, contributing to 64.5% of the global market share in 2023.

• Gas-filled detectors led in terms of detection type, holding the largest revenue share.

• The full-body protection segment was the top performer in the protection type category.

Order a free sample PDF of the Radiation Detection Monitoring And Safety Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 1.53 Billion

• 2030 Projected Market Size: USD 2.52 Billion

• CAGR (2024–2030): 7.4%

• North America: Largest market in 2023

• Asia Pacific: Fastest growing region

Key Company Insights

The market comprises key players who are enhancing their competitive positioning through mergers, acquisitions, and strategic partnerships. Prominent companies include:

• LANDAUER
• Mirion Technologies, Inc.
• Ludlum Measurements, Inc.
• Thermo Fisher Scientific Inc.
• Radiation Detection Company
• Arrow Tech.
• Centronic Limited
• Amray Group
• ATOMTEX

Mirion Technologies, Inc. offers a wide range of solutions such as spectroscopy and scientific analysis systems, health physics instruments, radiation monitoring systems, and more. It maintains strategic collaborations to promote workplace safety and enhance healthcare delivery.

LANDAUER provides comprehensive dosimetry services to various industries including medical, dental, nuclear, and research sectors. It also offers imaging physics services across multiple international markets.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global radiation detection, monitoring, and safety market is experiencing robust growth, driven by increasing cancer incidence, rising use of nuclear medicine, and growing emphasis on radiation safety. As governments and healthcare institutions continue to invest in advanced diagnostic tools and safety protocols, the market is expected to witness significant innovation and expansion in the coming years. With North America holding the leading share and Asia Pacific emerging rapidly, key players are well-positioned to capitalize on this rising demand.